Skip to main content
Top
Published in: Archives of Virology 10/2009

01-10-2009 | Original Article

Antibodies to PB1-F2 protein are induced in response to influenza A virus infection

Authors: Ingrid Krejnusová, Hana Gocníková, Magdaléna Bystrická, Hana Blaškovičová, Katarína Poláková, Jonathan Yewdell, Jack Bennink, Gustáv Russ

Published in: Archives of Virology | Issue 10/2009

Login to get access

Abstract

PB1-F2 is a small influenza A virus (IAV) protein encoded by an alternative (+1) reading frame of the PB1 gene. While dispensable for IAV replication in cultured cells, PB1-F2 has been implicated in IAV pathogenicity. To better understand PB1-F2 expression in vivo and its immunogenicity, we analyzed anti-PB1-F2 antibodies (Abs) in sera of mice infected intranasally (i.n.) with A/PR/8/34 (H1N1) virus and human acute and convalescent sera collected from the influenza H3N2 winter 2003–2004 epidemic. We explored a number of methods for detecting anti-PB1-F2 Abs, finding that PB1-F2-specific Abs could clearly be detected via immunoprecipitation or immunofluorescence assays using both immune mouse and human convalescent sera. Importantly, paired human sera exhibited similar increases in HI titers and PB1-F2-specific Abs. This study indicates that PB1-F2 is expressed in sufficient quantities in mice and humans infected with IAV to elicit an Ab response, supporting the biological relevance of this intriguing accessory protein.
Literature
1.
go back to reference Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, Bacik I, Basta S, O’Neill R, Schickli J, Palese P, Henklein P, Bennink JR, Yewdell JW (2001) A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 7:1306–1312PubMedCrossRef Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, Bacik I, Basta S, O’Neill R, Schickli J, Palese P, Henklein P, Bennink JR, Yewdell JW (2001) A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 7:1306–1312PubMedCrossRef
2.
go back to reference Pančuchárová H, Russ G (2006) PB1-F2 gene in influenza A viruses of different hemagglutinin subtype. Acta Virol 50:269–272PubMed Pančuchárová H, Russ G (2006) PB1-F2 gene in influenza A viruses of different hemagglutinin subtype. Acta Virol 50:269–272PubMed
3.
go back to reference Gocnikova H, Russ G (2007) Influenza a virus PB1-F2 protein. Acta Virol 51:101–108PubMed Gocnikova H, Russ G (2007) Influenza a virus PB1-F2 protein. Acta Virol 51:101–108PubMed
4.
go back to reference Gibbs JS, Malide D, Hornung F, Bennink JR, Yewdell JW (2003) The influenza A virus PB1-F2 protein targets the inner mitochondrial membrane via a predicted basic amphipathic helix that disrupts mitochondrial function. J Virol 77:7214–7224PubMedCrossRef Gibbs JS, Malide D, Hornung F, Bennink JR, Yewdell JW (2003) The influenza A virus PB1-F2 protein targets the inner mitochondrial membrane via a predicted basic amphipathic helix that disrupts mitochondrial function. J Virol 77:7214–7224PubMedCrossRef
5.
go back to reference Yamada H, Chounan R, Higashi Y, Kurihara N, Kido H (2004) Mitochondrial targeting sequence of the influenza A virus PB1-F2 protein and its function in mitochondria. FEBS Lett 578:331–336PubMedCrossRef Yamada H, Chounan R, Higashi Y, Kurihara N, Kido H (2004) Mitochondrial targeting sequence of the influenza A virus PB1-F2 protein and its function in mitochondria. FEBS Lett 578:331–336PubMedCrossRef
6.
go back to reference Zamarin D, Garcia-Sastre A, Xiao X, Wang R, Palese P (2005) Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog 1:40–54CrossRef Zamarin D, Garcia-Sastre A, Xiao X, Wang R, Palese P (2005) Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog 1:40–54CrossRef
7.
go back to reference Carr SM, Carnero E, García-Sastre A, Brownlee GG, Fodor E (2006) Characterization of a mitochondrial-targeting signal in the PB2 protein of influenza viruses. Virology 344:492–508PubMedCrossRef Carr SM, Carnero E, García-Sastre A, Brownlee GG, Fodor E (2006) Characterization of a mitochondrial-targeting signal in the PB2 protein of influenza viruses. Virology 344:492–508PubMedCrossRef
8.
go back to reference Mazur I, Anhlan D, Mitzner D, Wixler L, Schubert U, Ludwig S (2008) The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 protein. Cell Microbiol 10:1140–1152PubMedCrossRef Mazur I, Anhlan D, Mitzner D, Wixler L, Schubert U, Ludwig S (2008) The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 protein. Cell Microbiol 10:1140–1152PubMedCrossRef
9.
go back to reference Zamarin D, Ortigoza MB, Palese P (2006) Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol 80:7976–7983PubMedCrossRef Zamarin D, Ortigoza MB, Palese P (2006) Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol 80:7976–7983PubMedCrossRef
10.
go back to reference Coleman JR (2007) The PB1-F2 protein of influenza A virus: increasing pathogenicity by disrupting alveolar macrophages. Virol J 4:9–13PubMedCrossRef Coleman JR (2007) The PB1-F2 protein of influenza A virus: increasing pathogenicity by disrupting alveolar macrophages. Virol J 4:9–13PubMedCrossRef
11.
go back to reference McAuley JL, Hornung F, Boyd K, Smith AM, McKeon R, Bennink J, Yewdell JW, McCullers JA (2007) Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe 2:240–249PubMedCrossRef McAuley JL, Hornung F, Boyd K, Smith AM, McKeon R, Bennink J, Yewdell JW, McCullers JA (2007) Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe 2:240–249PubMedCrossRef
12.
go back to reference Russ G, Vareckova E, Styk B (1974) Steric effects in the reactions of influenza virus neuraminidase with antibodies. Acta Virol 18:299–306 Russ G, Vareckova E, Styk B (1974) Steric effects in the reactions of influenza virus neuraminidase with antibodies. Acta Virol 18:299–306
13.
go back to reference Chakrabarti S, Brechling K, Moss B (1985) Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Mol Cell Biol 5:3403–3409PubMed Chakrabarti S, Brechling K, Moss B (1985) Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Mol Cell Biol 5:3403–3409PubMed
14.
go back to reference Henklein P, Bruns K, Nimtz M, Wray V, Tessmer U, Schubert U (2005) Influenza A virus protein PB1-F2: synthesis and characterization of the biologically active full length protein and related peptides. J Pept Sci 10:481–490CrossRef Henklein P, Bruns K, Nimtz M, Wray V, Tessmer U, Schubert U (2005) Influenza A virus protein PB1-F2: synthesis and characterization of the biologically active full length protein and related peptides. J Pept Sci 10:481–490CrossRef
16.
go back to reference Yuwen H, Cox JH, Yewdell JW, Bennink JR, Moss B (1993) Nuclear localization of a double-stranded RNA binding protein encoded by the Vaccinia E3L gene. Virology 195:732–744PubMedCrossRef Yuwen H, Cox JH, Yewdell JW, Bennink JR, Moss B (1993) Nuclear localization of a double-stranded RNA binding protein encoded by the Vaccinia E3L gene. Virology 195:732–744PubMedCrossRef
17.
go back to reference Potter CW, Oxford JS (1979) Determinants of immunity to influenza infection in man. Br Med Bull 35:69–75PubMed Potter CW, Oxford JS (1979) Determinants of immunity to influenza infection in man. Br Med Bull 35:69–75PubMed
18.
go back to reference Kim WI, Wu WH, Janke B, Yoon KJ (2006) Characterization of the humoral immune response of experimentally infected and vaccinated pigs to swine influenza viral proteins. Arch Virol 151:23–36PubMedCrossRef Kim WI, Wu WH, Janke B, Yoon KJ (2006) Characterization of the humoral immune response of experimentally infected and vaccinated pigs to swine influenza viral proteins. Arch Virol 151:23–36PubMedCrossRef
19.
go back to reference Birch-Machin I, Rowan A, Pick J, Mumford J, Binns M (1997) Expression of the nonstructural protein NS1 of equine influenza A virus: detection of anti-NS1 Ab in post infection equine sera. J Virol Methods 65:255–263PubMedCrossRef Birch-Machin I, Rowan A, Pick J, Mumford J, Binns M (1997) Expression of the nonstructural protein NS1 of equine influenza A virus: detection of anti-NS1 Ab in post infection equine sera. J Virol Methods 65:255–263PubMedCrossRef
20.
go back to reference Tumpey TM, Alvarez R, Swayne DE, Suarez DL (2005) Diagnostic approach for differentiating infected from vaccinated poultry on the basis of Abs to NS1, the nonstructural protein of influenza A virus. J Clin Microbiol 43:676–683PubMedCrossRef Tumpey TM, Alvarez R, Swayne DE, Suarez DL (2005) Diagnostic approach for differentiating infected from vaccinated poultry on the basis of Abs to NS1, the nonstructural protein of influenza A virus. J Clin Microbiol 43:676–683PubMedCrossRef
21.
go back to reference Lambrecht B, Steensels M, Van Borm S, Meulemans G, van den Berg T (2007) Development of an M2e-specific enzyme-linked immunosorbent assay for differentiating infected from vaccinated animals. Avian Dis 51:221–226PubMedCrossRef Lambrecht B, Steensels M, Van Borm S, Meulemans G, van den Berg T (2007) Development of an M2e-specific enzyme-linked immunosorbent assay for differentiating infected from vaccinated animals. Avian Dis 51:221–226PubMedCrossRef
22.
go back to reference Black RA, Rota PA, Gorodkova N, Klenk HD, Kendal AP (1993) Antibody response to the M2 protein of influenza A virus expressed in insect cells. J Gen Virol 74:143–146PubMedCrossRef Black RA, Rota PA, Gorodkova N, Klenk HD, Kendal AP (1993) Antibody response to the M2 protein of influenza A virus expressed in insect cells. J Gen Virol 74:143–146PubMedCrossRef
23.
go back to reference Liu W, Li H, Chen YH (2003) N-terminus of M2 protein could induce antibodies with inhibitory activity against influenza virus replication. FEMS Immunol Med Microbiol 35:141–146PubMedCrossRef Liu W, Li H, Chen YH (2003) N-terminus of M2 protein could induce antibodies with inhibitory activity against influenza virus replication. FEMS Immunol Med Microbiol 35:141–146PubMedCrossRef
24.
go back to reference Feng J, Zhang M, Mozdzanowska K, Zharikova D, Hoff H, Wunner W, Couch RB, Gerhard W (2006) Influenza A virus infection engenders a poor Ab response against the ectodomain of matrix protein 2. Virol J 3:102–114PubMedCrossRef Feng J, Zhang M, Mozdzanowska K, Zharikova D, Hoff H, Wunner W, Couch RB, Gerhard W (2006) Influenza A virus infection engenders a poor Ab response against the ectodomain of matrix protein 2. Virol J 3:102–114PubMedCrossRef
25.
go back to reference Khurana S, Suguitan AL Jr, Rivera Y, Simmons CP, Lanzavecchia A, Sallusto F, Manischewitz J, King LR, Subbarao K, Golding H (2009) Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal abs reveals potential vaccine and diagnostic targets. PLoS Med 6(4):e1000049PubMedCrossRef Khurana S, Suguitan AL Jr, Rivera Y, Simmons CP, Lanzavecchia A, Sallusto F, Manischewitz J, King LR, Subbarao K, Golding H (2009) Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal abs reveals potential vaccine and diagnostic targets. PLoS Med 6(4):e1000049PubMedCrossRef
Metadata
Title
Antibodies to PB1-F2 protein are induced in response to influenza A virus infection
Authors
Ingrid Krejnusová
Hana Gocníková
Magdaléna Bystrická
Hana Blaškovičová
Katarína Poláková
Jonathan Yewdell
Jack Bennink
Gustáv Russ
Publication date
01-10-2009
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 10/2009
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-009-0479-5

Other articles of this Issue 10/2009

Archives of Virology 10/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine